GEN Exclusives

More »

GEN News Highlights

More »
Nov 18, 2010

Lonza and CPRI Ally on Peptide Manufacturing and Development Services

  • Lonza and California Peptide Research (CPRI) are joining forces to more effectively serve customers requesting peptide manufacturing and development services. CPRI’s high-quality small-scale services will complement Lonza's capabilities in custom cGMP peptide manufacturing and development.

    The alliance aims at providing customers with a more complete offering that spans research through to commercial supply. It will also enable a seamless transition of custom peptide projects between CPRI’s small-scale facility and Lonza’s cGMP facilities.

    Based in San Franciscon, CPRI's customer base in North America will add to Lonza's existing facilities in Braine-l'Alleud (Belgium), Visp (Switzerland), Nansha (China), and Kourim (Czech Republic).


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Children and Antipsychotic Drugs

Do you think children and adolescents with behavioral problems are overmedicated?